BHCM
BHC icon

Brevan Howard Capital Management’s Bausch Health BHC Stock Holding History

Brevan Howard Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-475,000
Closed -$3.07M – 1844
2025
Q1 		$3.07M Buy
+475,000
New +$3.41M 0.03% 219

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brevan Howard Capital Management's BHC Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 19,740 shares — an estimated $137K sold.

Brevan Howard Capital Management first reported a position in BHC in Q3 2022 and held it in 3 quarters. The position peaked at $1.22M in Q4 2022. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 19,740 Bausch Health shares in Q1 2026, an estimated $137K.
  • Brevan Howard Capital Management first reported a position in Bausch Health in Q3 2022 and held it in 3 quarters.
  • Brevan Howard Capital Management's Bausch Health position peaked at $1.22M in Q4 2022.
  • 228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.